Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2006-005926-22Phase 3Completed
Phase 3, randomised, open-label trial in asthma comparing FlutiForm arm with Seretide arm (2 arms). Primary endpoints: Mean forced expiratory volume in 1 second and Safety measured by forced expiratory volume in 1 second. Started Jan 2007; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2006-005926-22.